ProstaLund in brief

ProstaLund is a leading developer and manufacturer of innovative urological devices and treatments, primarily for benign prostatic hyperplasia (BPH), an age-related condition that results in urination problems for every second man over the age of 50.

ProstaLund began by developing products for treating urological conditions and rapidly started to focus on thermotherapy – using heat to treat BPH. The company developed a new microwave treatment method, CoreTherm®, which can be tailored to suit the needs of each individual patient.

ProstaLund has established, and maintains, close links with key opinion leaders and institutions in the world of urology. CoreTherm® has gained wide acceptance among leading urologists. This unique product lies at the heart of the company's ambition to provide a complete portfolio of patented treatments for BPH.

The company's vision is to relieve the problems that affect the quality of life that are associated with BPH, by providing sufferers with effective, minimally-invasive, individually tailored treatments.

A strong organisation has been established at the company base in Uppsala, Sweden and ProstaLund Operations AB has an efficient distribution network providing global coverage.